Could Genetically Engineered Humans Become a Reality?
By Robert King,
Washington Examiner
| 04. 30. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
Science is closer to creating genetically engineered human beings, and the advances in technology are sparking ethical arguments over making "a new kind of person."
The National Institutes of Health said Wednesday it would not fund any research into the gene editing of human embryos. The decision comes after Chinese researchers announced last week results from the first study to edit human embryo genes.
Gene editing, as the term implies, enables a scientist to cut DNA from a genome and insert it into another genome.
Theoretically an edited human embryo could then be implanted in a woman's uterus.
The goal is to edit the group of cells called the germline that could hand down diseases from one generation to the next. Researchers hope to prevent inherited diseases such as cystic fibrosis or sickle cell anemia from being passed on from a parent to a child.
The Chinese study was not successful. Scientists missed targets to place the DNA and discovered unknown mutations to cells.
However, the experiment has renewed talk in the scientific community of whether such research...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...